Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Dopamine Receptor d1 anticorps (AA 338-446)

DRD1 Reactivité: Rat WB, IHC, ICC, IP Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN1867631
  • Antigène Voir toutes Dopamine Receptor d1 (DRD1) Anticorps
    Dopamine Receptor d1 (DRD1) (Dopamine Receptor D1 (DRD1))
    Épitope
    • 16
    • 16
    • 14
    • 7
    • 7
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 338-446
    Reactivité
    • 80
    • 67
    • 44
    • 9
    • 7
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Rat
    Hôte
    • 86
    • 5
    • 1
    Lapin
    Clonalité
    • 78
    • 13
    Polyclonal
    Conjugué
    • 37
    • 8
    • 6
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Cet anticorp Dopamine Receptor d1 est non-conjugé
    Application
    • 69
    • 32
    • 27
    • 26
    • 26
    • 26
    • 17
    • 17
    • 16
    • 9
    • 8
    • 8
    • 2
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC), Immunoprecipitation (IP)
    Fonction
    Polyclonal Antibody to Dopamine Receptor D1 (DRD1)
    Specificité
    The antibody is a rabbit polyclonal antibody raised against DRD1. It has been selected for its ability to recognize DRD1 in immunohistochemical staining and western blotting.
     Réactivité croisée
    Humain, Souris
    Purification
    Antigen-specific affinity chromatography followed by Protein A affinity chromatography
    Immunogène
    Recombinant Dopamine Receptor D1 (DRD1) corresdonding to Gln338~Thr446 with N-terminal His Tag
    Isotype
    IgG
    Top Product
    Discover our top product DRD1 Anticorps primaire
  • Indications d'application

    Western blotting: 0.5-2 μg/mL Immunohistochemistry: 5-20 μg/mL Immunocytochemistry: 5-20 μg/mL Optimal working dilutions must be determined by end user.

    Commentaires

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    Lot specific
    Buffer
    PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.
    Conseil sur la manipulation
    Avoid repeated freeze/thaw cycles
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
    Date de péremption
    24 months
  • Antigène
    Dopamine Receptor d1 (DRD1) (Dopamine Receptor D1 (DRD1))
    Autre désignation
    Dopamine Receptor D1 (DRD1 Produits)
    Synonymes
    anticorps DRD1, anticorps Dop1, anticorps D1A, anticorps DADR, anticorps DRD1A, anticorps drd1, anticorps C030036C15Rik, anticorps Drd-1, anticorps Drd1, anticorps Gpcr15, anticorps D1a, anticorps Drd1a, anticorps dopamine receptor D1, anticorps dopamine receptor, D1, anticorps dopamine receptor D1b, anticorps DRD1, anticorps Dop1, anticorps drd1b, anticorps Drd1
    Sujet
    DR-D1, D1R, DADR, DRD1A
    Pathways
    cAMP Metabolic Process, Inositol Metabolic Process, Protein targeting to Nucleus, Feeding Behaviour, Smooth Muscle Cell Migration, Regulation of long-term Neuronal Synaptic Plasticity
Vous êtes ici:
Support technique